If you have rheumatoid arthritis and are considering compounded GLP-1 therapy for metabolic or weight-related comorbidities, this genetic context can support a deeper conversation with your provider about safety, potential off-label anti-inflammatory effects, and how to monitor disease activity alongside any new treatment
If the change is being advised due to mild common side effects, like constipation or bloating, a longer interval to wait may be advised, such as waiting closer to a month before starting a new GLP-1 agonist until all adverse effects have resolved
Personalized Weight Loss Care Dr
The key is to choose a supplement that your body can actually use
We used the proportion of patients covered as it is less affected by the length of the grace period compared with time-to-event analyses, and takes not only discontinuation but also reinitiation of treatment into account [31]
Microdosing is an evidence-backed strategy for reducing nausea and gastrointestinal adjustment during the early weeks of therapy
